| Followers | 12 |
| Posts | 1019 |
| Boards Moderated | 0 |
| Alias Born | 03/24/2013 |
Tuesday, January 09, 2018 3:45:42 AM
As the PR says they are about to start a pivotal clinical trial, is it fair to assume that either they have done the P1 / BE study already (unlikely) or the BE study will be built into the Pivotal trial itself.
I wonder how BE is done for intravitreal injectable products?
And by the time, biosimilars reach to market, they may have switched most patients to log acting version.
Eylea SR
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
